GE Healthcare Life Sciences Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines

GE Healthcare Life Sciences provides bioprocessing products and services to the biopharmaceutical industry for the development and production of vaccines and biotherapeutics.

The company uses its scientific knowledge and technical expertise to help biomanufacturers increase speed-to-market, reduce costs, and improve productivity.

Single-use, upstream and downstream bioprocessing

GE provides a wide range of integrated products and solutions to meet the needs of the biopharmaceutical industry for upstream and downstream bioprocessing.

Its portfolio includes products for cell culture and fermentation (HyClone™ cell culture media, sera, process liquids, ReadyToProcess WAVE™, Xcellerex™ bioreactors and Xcellerex fermentors), chromatography (ÄKTA™ chromatography system, chromatography columns and resins, and in-line conditioning systems), filtration (tangential flow filtration and ULTA™ normal flow filtration products), and liquid preparation and management (Xcellerex single-use mixers, ReadyKart™ mobile processing stations, ReadyToProcess™ storage bins and assemblies, and ReadyCircuit™ bag assemblies and ReadyMate™ connectors).

GE also offers single-use systems, components, assemblies, and manufacturing facility solutions.

Biomanufacturing design and management for therapies and vaccines

GE Healthcare offers drug developers an array of biomanufacturing solutions that increase efficiency and optimize productivity. GE’s Enterprise Solutions provide an end-to-end platform for biologics management with innovative, modular solutions for the launch of new molecules, bringing biosimilars to an emerging market, or expanding biomanufacturing capacity to support production needs. Enterprise Solutions provides clients with new options to achieve their biomanufacturing goals.

FlexFactory™ is an integrated, single-use, or hybrid biomanufacturing platform that provides rapid access to current good manufacturing practice (cGMP) manufacturing capacity, while providing flexibility.

The KuBio™ facilities and BioPark campus each offer a configurable design space to meet the client’s biomanufacturing needs. These turnkey facility solutions delay capital investment, reduce business risk, and improve speed-to-market.

Manufacturing support and strategies

GE provides a wide range of Fast Trak™ support services for drug development applications. Performed with open collaboration and transparency, the company offers services to support cell culture medium development, upstream and downstream process development, clinical manufacturing, analytical development, quality control, and process transfer.

In addition, GE offers education courses globally for practical, hands-on bioprocess training. Fast Trak courses are offered at 9 locations worldwide, in addition to on-demand courses.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

GE Healthcare’s FlexFactory Selected for Clover Biopharmaceuticals’ Changxing Zhejiang Facility

Clover Biopharmaceuticals has chosen GE Healthcare’s biomanufacturing platform FlexFactory for its new facility located in Changxing, Zhejiang, China.

Product and Services
White Papers

Case Study: Bioprocess Security of Supply

Human medicine manufacturers need suppliers who will consistently deliver high-quality consumables over decades and communicate transparently when changes are required. 

GE Healthcare Bio-Sciences AB - Sweden

Bjorkgatan 30

SE-75184 Uppsala


+ 46 771 400 600 + 46 18 612 19 10

GE Healthcare Life Sciences Images

Press Release

8 February 2018

Clover Biopharmaceuticals has chosen GE Healthcare’s biomanufacturing platform FlexFactory for its new facility located in Changxing, Zhejiang, China.

Read more
5 December 2017

United BioPharma (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan.

Read more
28 November 2017

GE has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry.

Read more
21 November 2017

GE Healthcare Life Sciences has announced a $7m expansion project at its single-use technology manufacturing facility in Westborough, US.

Read more
14 November 2017

GE Healthcare has announced that Dr. Reddy’s Laboratories will be installing India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India.

Read more

Regional Offices

GE Healthcare Bio-Sciences AB - Sweden

Bjorkgatan 30

SE-75184 Uppsala


+ 46 771 400 600 + 46 18 612 19 10
GE Healthcare Europe GmbH - Germany

Munzinger Strasse 5

D-79111 Freiburg


+49 0800 9080 711 +49 0800 9080 712
GE Healthcare UK Limited - UK

Amersham Place

Little Chalfont



United Kingdom

+44 0800 515 313 +44 0800 616 927
GE Healthcare Bio-Sciences Corp. - USA

100 Results Way

Marlborough, MA


United States of America

+ 1 800 526 3593 + 1 877 295 8102
GE Healthcare Japan Corporation - Japan

Sanken Bldg.3-25-1

Hyakunincho Shinjuku-ku

Tokyo 169-0073


+ 81 3 5331 9336 + 81 3 5331 9370

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.